About the research methods category
|
|
1
|
3838
|
April 17, 2020
|
Where are the exceptional responders?
|
|
1
|
92
|
July 25, 2024
|
Effect sizes for power and evidence for effectiveness
|
|
24
|
660
|
July 24, 2024
|
Power and sample size planning with canonical correlation analysis
|
|
3
|
99
|
July 23, 2024
|
Recovering utilities implicit in adaptive trial designs
|
|
5
|
198
|
July 18, 2024
|
Health economic state-based transition models
|
|
3
|
260
|
July 3, 2024
|
Progression in cancer trials
|
|
26
|
3834
|
June 25, 2024
|
Quality literature on the design and logistics of conducting a randomized controlled trial
|
|
4
|
3460
|
June 20, 2024
|
Power for a mixed ANOVA (2b x 2w)
|
|
2
|
275
|
June 8, 2024
|
Comparisons of Physicians and LLMs with Technical Replicates
|
|
1
|
253
|
June 6, 2024
|
Method comparison study: Multiple experts vs AI
|
|
8
|
763
|
May 21, 2024
|
Definition of Intention-to-Treat Set in Epic generated randomization
|
|
16
|
835
|
May 4, 2024
|
Double Counting in Meta-Analysis
|
|
3
|
324
|
April 10, 2024
|
Sample size calculation for metabolomic profiles in a nested case-control study
|
|
0
|
298
|
April 8, 2024
|
Immortal-time-bias vs. selection bias
|
|
2
|
337
|
April 7, 2024
|
Run-in phase in RCTs
|
|
14
|
9777
|
April 1, 2024
|
Calculate incidence rate after adjustment
|
|
10
|
1482
|
March 19, 2024
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
483
|
February 23, 2024
|
Problems with NNT
|
|
36
|
34016
|
February 19, 2024
|
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic
|
|
34
|
3347
|
February 16, 2024
|
RCT: protocol deviation and implications for analysis
|
|
6
|
469
|
February 16, 2024
|
Handling missing continuous data due to death
|
|
7
|
535
|
February 8, 2024
|
Sample Size calculation - "subgroup hypothesis", Guidance needed
|
|
2
|
519
|
February 4, 2024
|
ITT analysis population - RCT
|
|
6
|
953
|
February 3, 2024
|
Practicalities of using Markov Longitudinal Ordinal Models in Cardiovascular Outcome Trials
|
|
5
|
662
|
January 25, 2024
|
Mixed vs Random Effects ICC
|
|
13
|
16847
|
January 23, 2024
|
Random vs. fixed effects meta-analysis
|
|
22
|
3962
|
January 20, 2024
|
Calculate event/total of an outcome that is reported as Hazard Ratio (95% CI, p-value)
|
|
1
|
333
|
January 10, 2024
|
Language for communicating frequentist results about treatment effects
|
|
200
|
111705
|
January 9, 2024
|
Substituting treatment arm with drug exposure (continuous variable) in RCT
|
|
10
|
664
|
January 8, 2024
|